Toggle Main Menu Toggle Search

Open Access padlockePrints

Insights and future directions of potential genetic therapy for Apert syndrome: A systematic review

Lookup NU author(s): Dr Nisreen Al-NamnamORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Apert syndrome is a genetic disorder characterized by craniosynostosis and structural discrepancy of the craniofacial region as well as the hands and feet. This condition is closely linked with fibroblast growth factor receptor-2 (FGFR2) gene mutations. Gene therapies are progressively being tested in advanced clinical trials, leading to a rise of its potential clinical indications. In recent years, research has made great progress in the gene therapy of craniosynostosis syndromes and several studies have investigated its influences in preventing/diminishing the complications of Apert syndrome. This article reviewed and exhibited different techniques of gene therapy and their influences in Apert syndrome progression. A systematic search was executed using electronic bibliographic databases including PubMed, EMBASE, ScienceDirect, SciFinder and Web of Science for all studies of gene therapy for Apert syndrome. The primary outcomes measurements vary from protein to gene expressions. According to the findings of included studies, we conclude that the gene therapy using FGF in Apert syndrome was critical in the regulation of suture fusion and patency, occurred via alterations in cellular proliferation. The superior outcome could be brought by biological therapies targeting the FGF/FGFR signalling. More studies in molecular genetics in Apert syndrome are recommended. This study reviews the current literature and provides insights to future possibilities of genetic therapy as intervention in Apert syndrome.


Publication metadata

Author(s): Al-Namnam NM, Jayash SN, Hariri F, Rahman ZA, Alshawsh MA

Publication type: Article

Publication status: Published

Journal: Gene Therapy

Year: 2021

Volume: 28

Pages: 620–633

Print publication date: 01/11/2021

Online publication date: 22/02/2021

Acceptance date: 03/02/2021

ISSN (print): 0969-7128

ISSN (electronic): 1476-5462

Publisher: Nature Publishing Group

URL: https://doi.org/10.1038/s41434-021-00238-w

DOI: 10.1038/s41434-021-00238-w


Altmetrics

Altmetrics provided by Altmetric


Share